drugset / Trial / NCT02978144
Lung Imaging of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)
Phase 2
Terminated
34 enrolled
Columbia University
National Heart, Lung, and Blood Institute (NHLBI) · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This is a prospective interventional study examining the use of Annexin - a radioactive tracer, in assessing lung damage in healthy volunteers, healthy volunteers actively smoking, and patients with moderate and severe chronic obstructive pulmonary disease (COPD). All study participants will undergo a CT scan, pulmonary testing, and blood test. The study procedures are done in one day. The aim of this study is to determine if Annexin can be used as a marker to detect lung injury early on and aid in the future diagnosis of COPD.
Timeline
- Start
- 2017-06-15
- Primary completion
- 2019-10-08
- Completion
- 2019-10-08
Outcome
Outcome not reported
Stopped: “Difficulty finding Annexin study drug supplier”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AxV-128/Tc | Diagnostic / imaging agent | — | Intravenous |